Top Companies in Prescription Drugs Market by Size, Share, Historical and Future Data & CAGR | Report by Vantage Market Research
Prescription Drugs Market is projected to reach a value of USD 1.4 Billion by 2030 at a CAGR of 8.5% over the forecast period.
Vantage Market Research has recently published a new report on "Prescription Drugs Market” Global Industry Assessment & Forecast to identify key trends and challenges. The report offers insights into the competitive landscape, prospects, and key investment considerations for businesses operating in Prescription Drugs market. Some of the key statistics in the report highlight that Global Prescription Drugs Market was valued at USD 0.8 Billion in 2022 and is projected to reach a value of USD 1.4 Billion by 2030 at a CAGR of 8.5% over the forecast period. The global Prescription Drugs market will continue to expand due to increasing prevalence of chronic diseases, aging population, advances in drug development and increasing healthcare spending.
Request Sample Report of Prescription Drugs Market @ https://www.vantagemarketresearch.com/prescription-drugs-market-2088/request-sample
The Global Prescription Drugs Market is dominated by well- known players F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi S.A (France), Pfizer Inc. (U.S.), GlaxoSmithKline PLC (U.K.), Novartis AG (Switzerland), Merck & Co. Inc. (U.S.), AstraZeneca PLC (U.K.), Bristol-Myers Squibb Company (U.S.), Boehringer Ingelheim International GmbH. (Germany), to name a few.
Let’s Take a Look at the Top Market Players that are Captivating the Prescription Drugs Market
- F. Hoffmann-La Roche Ltd. (Switzerland)
The primary areas of concentration for the business include the discovery, production, and commercialization of prescription drugs for a variety of illnesses, including cancer, infectious diseases, ophthalmology, and neuroscience, among others. Herceptin, Avastin, and Rituxan are just a few of the company's well-known cancer drugs. The company also has a significant presence in the diagnostics sector in addition to its pharmaceutical business, delivering a variety of diagnostic tests and platforms for consumers and healthcare professionals.
- Teva Pharmaceutical Industries Ltd. (Ireland)
The business offers specialized medications to treat ailments including cancer, respiratory, dermatological, women's health, and central nervous system (CNS) disorders. In addition to capsules, pills, injectables, liquids, inhalants, creams, and ointments, it also offers generic medications in a variety of dosage forms. In addition to active medicinal components, Teva also sells over-the-counter (OTC) goods (APIs). Teva Pharmaceutical Industries provides services to clients all around the world.
- Sanofi S.A (France)
The company's product line also includes human vaccinations for defence against numerous bacterial and viral infections as well as medications for the treatment of cancer, diabetes, uncommon disorders, multiple sclerosis, and cardiovascular diseases. Also, the company sells consumer healthcare items for women's health, digestion, allergy, cough, cold, flu, and sinuses, pain, and vitamins, minerals, and supplements.
- Pfizer Inc. (U.S.)
Pfizer runs its business through two primary divisions: Upjohn and Pfizer Biopharmaceuticals Group (PBG). Prescription drug development and commercialization for a variety of therapeutic areas, such as oncology, inflammation, immunology, rare diseases, vaccines, and others, are included in the PBG section. Upjohn, a recently separated company, specialises in the creation of non-patent medications for diverse therapeutic applications.
- GlaxoSmithKline PLC (U.K.)
The corporation conducts operations in the pharmaceuticals, vaccines, and consumer healthcare sectors. Prescription medications for a range of illnesses, including HIV, respiratory, cancer, immuno-inflammation, and vaccines, are included in the pharmaceuticals section. There are vaccines for meningitis, shingles, influenza, and other diseases in the vaccines category. Over-the-counter medications, dental care items, and dietary supplements are all included in the consumer healthcare market.
- Novartis AG (Switzerland)
Novartis AG, a multinational pharmaceutical corporation based in Switzerland, combined Ciba-Geigy and Sandoz. The business creates and manufactures medications for a variety of illnesses, including as cancer, cardiovascular diseases, respiratory problems, and neurological ailments. Novartis also has divisions that are focused on eye care goods (Alcon) and generics in addition to its pharmaceutical business (Sandoz).
- Merck & Co. Inc. (U.S.)
A biopharmaceutical firm, Merck & Co. Inc. is dedicated to the discovery, development, production, and commercialization of pharmaceuticals, biologic therapies, vaccines, and animal health products. It provides products on prescription for the treatment of diabetes, immunological disorders, infectious diseases, cancer, cardiovascular diseases, and cancers of the breast and uterus. The business also sells vaccinations, poultry, cattle, and aquaculture products, among other animal health products. Merck provides managed healthcare services to hospitals, government organisations, wholesalers, retailers, and hospitals. It also provides veterinarians, distributors, and animal producers with animal health products.
- AstraZeneca PLC (U.K.)
The company's main areas of interest include the creation, production, and marketing of prescription drugs for a variety of illnesses, such as cancer, respiratory, cardiovascular, and metabolic problems. Several of the best-selling medicines in the world, like Crestor, Nexium, and Seroquel, are part of AstraZeneca's diverse product line.
- Bristol-Myers Squibb Company (U.S.)
The company's product offerings are some well-known pharmaceuticals, such as Opdivo, Eliquis, and Orencia. The business is notably well-known for its oncology medications, which were created to treat a variety of cancers.
- Boehringer Ingelheim International GmbH (Germany)
The company's medications are used to treat a variety of illnesses, including oncology, immunology, and disorders of the central nervous system, as well as respiratory, cardiovascular, and metabolic disorders.Spiriva for chronic obstructive pulmonary disease (COPD), Pradaxa for stroke prevention in people with atrial fibrillation, and Ofev for idiopathic pulmonary fibrosis are a few of the company's well-known medications. With its products for the prevention and treatment of diseases in livestock, pets, and horses, the company also has a significant position in the animal health sector.
Read Our Latest Blog: Top Companies in Nuclear Decommissioning Services Market
Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: Vantage Market Research